Tenet Healthcare (NYSE:THC) Director Tammy Romo Sells 4,922 Shares of Stock

Key Points

• Insider selling: Tenet Healthcare Director Tammy Romo sold 4,922 shares for approximately $1.3 million, reducing her direct stake by 13.78%; she also sold an additional 2,500 shares the following day.
• Strong financial results: Tenet reported quarterly earnings of $6.12 per share, exceeding estimates by $1.86, while revenue reached $6.04 billion and increased 6.8% year over year.
• Analyst outlook remains positive: Tenet has a “Moderate Buy” consensus rating, with 17 Buy ratings and three Holds and an average price target of $272.25, compared with shares recently trading near $260.

Tenet Healthcare Corporation (NYSE:THC - Get Free Report) Director Tammy Romo sold 4,922 shares of the business's stock in a transaction that occurred on Thursday, August 6th. The shares were sold at an average price of $264.15, for a total value of $1,300,146.30. Following the completion of the sale, the director directly owned 30,784 shares of the company's stock, valued at approximately $8,131,593.60. The trade was a 13.78% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Tammy Romo also recently made the following trade(s):

• On Friday, August 7th, Tammy Romo sold 2,500 shares of Tenet Healthcare stock. The shares were sold at an average price of $260.83, for a total transaction of $652,075.00.

Tenet Healthcare Stock Down 0.7%

Shares of THC traded down $1.80 during mid-day trading on Monday, hitting $260.33. 889,058 shares of the company's stock were exchanged, compared to its average volume of 1,475,405. The stock has a market cap of $20.96 billion, a price-to-earnings ratio of 10.04, a P/E/G ratio of 1.00 and a beta of 1.23. Tenet Healthcare Corporation has a twelve month low of $157.58 and a twelve month high of $265.32. The firm has a fifty day moving average of $202.01 and a two-hundred day moving average of $201.90. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00.

Tenet Healthcare (NYSE:THC - Get Free Report) last posted its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, beating the consensus estimate of $4.26 by $1.86. The company had revenue of $6.04 billion for the quarter, compared to analyst estimates of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The business's revenue was up 6.8% compared to the same quarter last year. During the same period last year, the company earned $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. On average, sell-side analysts forecast that Tenet Healthcare Corporation will post 21.09 earnings per share for the current year.

Hedge Funds Weigh In On Tenet Healthcare

Institutional investors and hedge funds have recently bought and sold shares of the stock. Swedbank AB boosted its stake in Tenet Healthcare by 14.7% in the fourth quarter. Swedbank AB now owns 146,133 shares of the company's stock worth $29,040,000 after purchasing an additional 18,750 shares in the last quarter. Jackson Creek Investment Advisors LLC increased its stake in shares of Tenet Healthcare by 235.6% in the fourth quarter. Jackson Creek Investment Advisors LLC now owns 9,032 shares of the company's stock valued at $1,795,000 after buying an additional 6,341 shares in the last quarter. Hsbc Holdings PLC raised its holdings in shares of Tenet Healthcare by 3,478.7% in the fourth quarter. Hsbc Holdings PLC now owns 266,400 shares of the company's stock valued at $53,269,000 after buying an additional 258,956 shares during the last quarter. Brandywine Global Investment Management LLC grew its holdings in Tenet Healthcare by 20.5% during the 4th quarter. Brandywine Global Investment Management LLC now owns 126,248 shares of the company's stock worth $25,088,000 after acquiring an additional 21,435 shares during the last quarter. Finally, Louisiana State Employees Retirement System acquired a new stake in Tenet Healthcare in the 1st quarter valued at about $4,812,000. Institutional investors own 95.44% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on THC shares. The Goldman Sachs Group reiterated a "buy" rating and set a $305.00 price target on shares of Tenet Healthcare in a report on Tuesday, July 28th. UBS Group upped their price objective on shares of Tenet Healthcare from $288.00 to $308.00 and gave the stock a "buy" rating in a report on Monday, July 27th. Barclays lifted their target price on shares of Tenet Healthcare from $240.00 to $271.00 and gave the stock an "overweight" rating in a report on Friday, July 24th. Robert W. Baird upped their price target on shares of Tenet Healthcare from $210.00 to $280.00 and gave the company a "neutral" rating in a report on Tuesday, July 28th. Finally, Weiss Ratings lowered Tenet Healthcare from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Tuesday, June 2nd. Seventeen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Tenet Healthcare currently has a consensus rating of "Moderate Buy" and an average target price of $272.25.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source